Safety, efficacy, and biomarker findings of PBT2 in targeting A beta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial Journal Articles Refereed uri icon

Overview

Authors

Published in

  • The Lancet Neurology

Time

Date/time value

  • 2008

Identity

Digital Object Identifier (DOI)

  • 10.1016/S1474-4422(08)70167-4

Additional Document Info

Parent Title

  • LANCET NEUROLOGY

Volume

  • 7

Issue

  • 9

Publisher

  • The Lancet Publishing Group